Literature DB >> 2407083

The independence of cycle length variability and exercise testing on predicting mortality of patients surviving acute myocardial infarction. The Multicenter Postinfarction Research Group.

R E Kleiger1, J P Miller, R J Krone, J T Bigger.   

Abstract

Cycle length variability (CLV), defined as the standard deviation of normal cycle length intervals, has been found to be a powerful predictor of subsequent mortality in a population of 808 survivors of acute myocardial infarction. Decreased CLV is associated with a significant increase in mortality. CLV remained an independent predictor of outcome even after adjusting for left ventricular ejection fraction, clinical risk factors, heart rate and ventricular arrhythmias. In the same population of survivors of acute myocardial infarction, the results of exercise testing also strongly predicted outcome, with those failing to take the test having the worst survival, and those completing the low-level stress test taken before discharge having the best prognosis. The hypothesis that the status of stress test (completed; did not complete; failed to take) and CLV were measuring the same factor related to mortality was tested. Although the distribution of CLV was shifted to higher CLV in patients who completed the test and to lower CLV in those who failed to take the test, both predictors of mortality remained independent predictors of long-term mortality (average of 31 months of follow-up) after controlling for each other. Moreover, subgroups with an approximate 15-fold difference in mortality were defined using both variables (CLV less than 50 ms, did not take test had a 54% mortality; CLV greater than 100 ms, completed the test had a mortality of 3.5%). CLV is a measure of autonomic tone; it is not strongly related to exercise ability and using the results of both stress testing and CLV results in the identification of subgroups of postinfarction patients with markedly disparate risks of mortality.

Entities:  

Mesh:

Year:  1990        PMID: 2407083     DOI: 10.1016/0002-9149(90)90801-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Non-invasive risk stratification: prognostic implications of exercise testing.

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03

Review 2.  Application of chaos theory to biology and medicine.

Authors:  J E Skinner; M Molnar; T Vybiral; M Mitra
Journal:  Integr Physiol Behav Sci       Date:  1992 Jan-Mar

3.  Point-of-care testing of cardiac autonomic function for risk assessment in patients with suspected acute coronary syndromes.

Authors:  C Eick; M Duckheim; P Groga-Bada; N Klumpp; S Mannes; C S Zuern; M Gawaz; K D Rizas; Axel Bauer
Journal:  Clin Res Cardiol       Date:  2017-03-22       Impact factor: 5.460

4.  Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome.

Authors:  Benjamin N Schaeffer; Meike Rybczynski; Sara Sheikhzadeh; Ruken Ö Akbulak; Julia Moser; Mario Jularic; Doreen Schreiber; Anne Daubmann; Stephan Willems; Yskert von Kodolitsch; Boris A Hoffmann
Journal:  Clin Res Cardiol       Date:  2015-06-02       Impact factor: 5.460

Review 5.  Heart rate variability: measurement and clinical utility.

Authors:  Robert E Kleiger; Phyllis K Stein; J Thomas Bigger
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-01       Impact factor: 1.468

6.  Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.

Authors:  Shigeki Nagamachi; Seigo Fujita; Ryuichi Nishii; Shigemi Futami; Shozo Tamura; Masanari Mizuta; Masamitsu Nakazato; Takeshi Kurose; Hideyuki Wakamatsu
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

7.  Effect of heart rate correction on pre- and post-exercise heart rate variability to predict risk of mortality-an experimental study on the FINCAVAS cohort.

Authors:  Paruthi Pradhapan; Mika P Tarvainen; Tuomo Nieminen; Rami Lehtinen; Kjell Nikus; Terho Lehtimäki; Mika Kähönen; Jari Viik
Journal:  Front Physiol       Date:  2014-06-03       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.